New

Milo Healthcare

The AI engine Fit Assessment

Beta

Milo develops digital solutions that streamline clinical processes and operates within the pharmaceutical and biotech industries.

Blurb

Developer of clinical data tool and clinical trials platform designed to help clients from industries like pharma and biotech, device and diagnostic, and contract research organizations. The company's platform streamlines processes standardize workflows, enhances participant engagement, and offers features like total consent management for streamlined onboarding, televisit scheduling for global accessibility, and patient-first data generation for high-quality data collection and operational dashboards provide comprehensive study control, while its distributed computing technology ensures global accessibility.

HQ Location

Paris (France)

Founded

2024

Employees

11 - 50

Total funding raised

Not available

Funding Status

Not available

Milo is a next-generation Electronic Data Capture (EDC) platform designed to meet the evolving needs of clinical trials in the MedTech.



Developed by an expert CRO, Milo enables multimodal data capture (voice, image, video), integrates AI-powered automation for risk prediction and monitoring, and offers native interoperability with Electronic Health Records (EHRs) via FHIR.



Our mission is to make clinical data collection faster, smarter, and submission-ready, while maintaining full compliance with global standards (GAMP5, 21 CFR Part 11, ISO 27001, HDS).